CompletedNot Applicable

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

220 participantsStarted 2012-01-03

Plain-language summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and lean more about biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood samples from patients with acute myeloid leukemia.

Who can participate

Age range17 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Morphologically confirmed acute myeloid leukemia (AML) * Newly diagnosed with AML * Serum samples from patients enrolled on the ECOG-1900 clinical trial between 2002 and 2008 * Patients with or without isocitrate dehydrogenase (IDH) mutations PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Received 2 different doses of standard induction chemotherapy on ECOG-1900

What they're measuring

Absence of serum 2HG in all samples without an IDH mutation

Timeframe: 1 day

Trial details

NCT IDNCT01385150

SponsorEastern Cooperative Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2012-02-03

View on ClinicalTrials.gov More Leukemia trials